Maravai LifeSciences(MRVI) - 2025 Q4 - Earnings Call Presentation

NASDAQ: MRVI Q4 and Year-end 2025 Financial Results February 25, 2026 Agenda | 01 | Welcome | Deb Hart, Head of Investor Relations | | --- | --- | --- | | 02 | Business Highlights | Bernd Brust, Chief Executive Officer | | 03 | Financial Results | Raj Asarpota, Chief Financial Officer | | | & Guidance | | | 04 | Q&A Session | Bernd Brust, Chief Executive Officer | | | | Raj Asarpota, Chief Financial Officer | | | | Chanfeng Zhao, Chief Scientific Officer | ©2026 Maravai LifeSciences. This document and its c ...